Quantification of Immunoglobulin G against Trypanosoma cruzi in Individuals with Chronic Chagas Disease Treated with Nifurtimox and Evaluated in Prolonged Follow-Up |
Munoz, Gabriela
(Laboratory of Basic-Clinical Parasitology, Program of Cellular and Molecular Biology, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile)
Vergara, Camilo (Laboratory of Basic-Clinical Parasitology, Program of Cellular and Molecular Biology, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile) Martinez, Gabriela (Laboratory of Basic-Clinical Parasitology, Program of Cellular and Molecular Biology, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile) Apt, Werner (Laboratory of Basic-Clinical Parasitology, Program of Cellular and Molecular Biology, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile) Zulantay, Ines (Laboratory of Basic-Clinical Parasitology, Program of Cellular and Molecular Biology, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile) |
1 | World Health Organization. Chagas disease in Latin America: an epidemiological update based on 2010 estimates. Wkly Epidemiol Rec 2015; 90: 33-44. |
2 | Perez-Molina JA, Molina I. Chagas disease. Lancet 2018; 391: 82-94. DOI |
3 | Apt W, Zulantay I. Estado actual en el tratamiento de la enfermedad de Chagas. Rev Med Chile 2011; 139: 247-257 (in Spanish). DOI |
4 | Bern C. Antitrypanosomal therapy for chronic Chagas' disease. N Engl J Med 2011; 364: 2527-2534. DOI |
5 | Sguassero Y, Cuesta CB, Roberts KN, Hicks E, Comande D, Ciapponi A, Sosa-Estani S. Course of chronic Trypanosoma cruzi infection after treatment based on parasitological and serological test: a systematic review of follow-up studies. PLoS One 2015; 10: e0139363. DOI |
6 | Ministerio de Salud. Guia de diagnostico, tratamiento y prevencion de la enfermedad de Chagas. Guias Clinicas 2011 (in Spanish). |
7 | Flores-Chavez M, Cruz I, Rodriguez M, Nieto J, Franco E, Garate T, Canavate C. Comparacion de tecnicas serologicas convencionales y no convencionales para el diagnostico de la enfermedad de Chagas importada en Espana. Enferm Infecc Microbiol Clin 2010; 28: 284-293. DOI |
8 | Astorga B, Lorca M, Thiermann E. Determinacion de la reaccion de Inmunofluorescencia indirecta para la enfermedad de Chagas en Chile. Parasitologia al Dia 1998; 12: 132-135 (in Spanish). |
9 | Luquetti A, Rassi A. Perspectiva del uso de la serologia (Ag naturales y otros) en la evaluacion de la eficacia del tratamiento etiologico. 2nd Simposio Internacional de Enfermedad de Chagas 2002 (in Spanish). |
10 | Rassi A, Luquetti A. Specific treatment for Trypanosoma cruzi: lack of efficacy of allopurinol in the human chronic phase of Chagas disease. Am J Trop Med Hyg 2007; 76:58-61. DOI |
11 | Luquetti A, Schmunis G. Diagnosis of Trypanosoma cruzi infection. In Telleira J, Tibayrenc M, eds, American Trypanosomiasis Chagas Disease. 2nd ed. Amsterdam, Netherlands. Elsevier. 2017, pp 687-730. |
12 | Cabello C, Cabello F. Zoonosis con reservorios silvestres: amenazas a la salud publica y a la economia. Rev Med Chile 2008; 136: 385-393 (in Spanish). |
13 | Toso A, Vial F, Galanti N. Transmision de la enfermedad de Chagas por via oral. Rev Med Chile 2011; 139: 258-266 (in Spanish). DOI |
14 | Rassi A Jr, Rassi A, Marcondes de Rezende J. American Trypanosomiasis (Chagas disease). Infect Dis Clin North Am 2012; 26: 275-291. DOI |